Trial Profile
A single-center, open-label, randomized, multiple-dose, 3-treatment, 3-way crossover study to study three up-titration regimens of ponesimod in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 17 Nov 2015 New trial record